Suppr超能文献

导丝鞘/导引导管联合与无导丝鞘导引导管在急性冠状动脉综合征中的应用:两种器械的倾向性匹配分析。

Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices.

机构信息

Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.

Department of Data Science, Yokohama City University School of Data Science, Yokohama, Japan.

出版信息

J Interv Cardiol. 2020 Aug 14;2020:8216831. doi: 10.1155/2020/8216831. eCollection 2020.

Abstract

A Glidesheath slender (Terumo, Tokyo, Japan) and a sheathless Eaucath guiding catheter (Asahi Intecc, Nagoya, Japan) are two major slender devices utilized in percutaneous coronary intervention (PCI). This study aimed to investigate the differences in access-site complications between these devices in PCI for acute coronary syndrome (ACS). A total of 1108 consecutive patients who underwent transradial PCI for ACS were enrolled. Transradial PCI was performed using either a 7-Fr Glidesheath slender/7-Fr guiding catheter combination (Glidesheath group) or a 7.5-Fr sheathless guiding catheter (Sheathless group); 1 : 1 propensity score matching was performed, and 728 patients (364 in each group) were included in the propensity-matched population. In the matched patients, univariate analysis revealed that the Glidesheath group had less radial artery occlusion (RAO) at 30 days (Glidesheath: 1.4% vs. Sheathless: 4.1%, odds ratio (OR) = 0.33, 95% confidence interval (CI) =  0.12-0.91, =0.039), whereas no significant between-group differences were observed in severe radial spasm (Glidesheath: 1.4% vs. Sheathless: 1.9%, OR = 0.71, 95% CI = 0.23-2.22, =0.58) or access-site major bleeding (Glidesheath: 1.4% vs. Sheathless: 1.6%, OR = 0.83, 95% CI = 0.26-2.71, =1.00). Multivariate analysis revealed that the choice for Glidesheath was significantly associated with less RAO (OR = 0.32, 95% CI = 0.11-0.93, =0.036). In conclusion, 7-Fr Glidesheath slender/7-Fr guiding catheter combination is obviously more advantageous than 7.5-Fr sheathless guiding catheters for decreased risk of RAO. The potential low risk of RAO in our findings supports the adoption of the 7-Fr Glidesheath slender sheath/7-Fr guiding catheter combination in transradial PCI for ACS.

摘要

使用 GlideSheath 细鞘(Terumo,东京,日本)和无鞘 Eaucath 引导导管(Asahi Intecc,名古屋,日本)是经皮冠状动脉介入治疗(PCI)中两种主要的细鞘设备。本研究旨在探讨这两种设备在急性冠状动脉综合征(ACS)患者 PCI 中的入路部位并发症的差异。共纳入 1108 例连续接受经桡动脉 PCI 的 ACS 患者。经桡动脉 PCI 使用 7Fr GlideSheath 细鞘/7Fr 引导导管组合(GlideSheath 组)或 7.5Fr 无鞘引导导管(Sheathless 组)进行;采用 1:1 倾向评分匹配,将 728 例患者(每组 364 例)纳入倾向评分匹配人群。在匹配患者中,单因素分析显示,GlideSheath 组 30 天桡动脉闭塞(RAO)发生率较低(GlideSheath:1.4% vs. Sheathless:4.1%,比值比(OR)=0.33,95%置信区间(CI)=0.12-0.91,=0.039),但两组严重桡动脉痉挛(GlideSheath:1.4% vs. Sheathless:1.9%,OR=0.71,95%CI=0.23-2.22,=0.58)或入路部位大出血(GlideSheath:1.4% vs. Sheathless:1.6%,OR=0.83,95%CI=0.26-2.71,=1.00)发生率无显著差异。多因素分析显示,选择 GlideSheath 与 RAO 发生率降低显著相关(OR=0.32,95%CI=0.11-0.93,=0.036)。总之,7Fr GlideSheath 细鞘/7Fr 引导导管组合明显优于 7.5Fr 无鞘引导导管,可降低 RAO 风险。我们的研究结果表明,RAO 发生风险低,支持在经桡动脉 PCI 治疗 ACS 中采用 7Fr GlideSheath 细鞘/7Fr 引导导管组合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1320/7443233/baaaa637598b/JITC2020-8216831.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验